Zaderej Karen L. — SEC Form 4 filings
SEC reporting owner CIK 1530968. 10 Form 4 filings on record with FilingPulse; latest filed 2026-08-18.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-01-09 to 2026-08-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 6 legs across 4 filings — 43,100 shares, $265,458 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 3 legs across 1 filing — 39,280 shares, $301,670 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 33,028 shares @ $7.68 ($253,655) in Axogen, Inc., filed 2024-03-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Axogen, Inc. (AXGN) | CEO, Director | 1 | — | 3 legs · 39,280 sh · $301,670 | 6 |
| EyePoint, Inc. (EYPT) | Director | 9 | 6 legs · 43,100 sh · $265,458 | — | 7 |
Form 4 filings — Zaderej Karen L.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-18 | 4 | EyePoint, Inc. (EYPT) | Purchase (P): 10,600 @ $4.93 | EDGAR |
| 2026-01-06 | 4 | EyePoint, Inc. (EYPT) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-07-11 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Option exercise (M): 2,000 @ $0 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Purchase (P): 5,000 @ $5.81 · Purchase (P): 5,000 @ $5.99 | EDGAR |
| 2025-05-15 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Purchase (P): 5,000 @ $5.42 · Purchase (P): 5,000 @ $5.47 | EDGAR |
| 2025-01-07 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-08-21 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Purchase (P): 12,500 @ $7.98 | EDGAR |
| 2024-07-12 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Option exercise (M): 2,000 @ $0 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2024-03-25 | 4 | Axogen, Inc. (AXGN) | Option exercise (M): 84,847 @ $0 · Sale (S): 33,028 @ $7.68 · Option exercise (M): 12,500 @ $0 · Sale (S): 3,086 @ $7.68 · Option exercise (M): 12,975 @ $0 · Sale (S): 3,166 @ $7.68 · +3 more | EDGAR |
| 2024-01-09 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Grant/award (A): 25,014 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1530968 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →